Placebo Effect
"Placebo Effect" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An effect usually, but not necessarily, beneficial that is attributable to an expectation that the regimen will have an effect, i.e., the effect is due to the power of suggestion.
Descriptor ID |
D015990
|
MeSH Number(s) |
N05.715.350.350.625 N06.850.490.734.875
|
Concept/Terms |
Placebo Effect- Placebo Effect
- Effect, Placebo
- Effects, Placebo
- Placebo Effects
|
Below are MeSH descriptors whose meaning is more general than "Placebo Effect".
Below are MeSH descriptors whose meaning is more specific than "Placebo Effect".
This graph shows the total number of publications written about "Placebo Effect" by people in this website by year, and whether "Placebo Effect" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 0 | 1 | 1 | 2006 | 0 | 2 | 2 | 2007 | 0 | 1 | 1 | 2008 | 2 | 2 | 4 | 2012 | 0 | 2 | 2 | 2014 | 1 | 1 | 2 | 2016 | 0 | 3 | 3 | 2017 | 2 | 0 | 2 | 2018 | 0 | 1 | 1 | 2019 | 0 | 2 | 2 | 2021 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Placebo Effect" by people in Profiles.
-
Huneke NTM, Chamberlain SR, Baldwin DS, Grant JE. Diverse predictors of treatment response to active medication and placebo in gambling disorder. J Psychiatr Res. 2021 12; 144:96-101.
-
Barnes K, Rottman BM, Colagiuri B. The placebo effect: To explore or to exploit? Cognition. 2021 09; 214:104753.
-
Goel G, Tye-Din JA, Qiao SW, Russell AK, Mayassi T, Ciszewski C, Sarna VK, Wang S, Goldstein KE, Dzuris JL, Williams LJ, Xavier RJ, Lundin KEA, Jabri B, Sollid LM, Anderson RP. Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease. Sci Adv. 2019 08; 5(8):eaaw7756.
-
Mahaffey KW, Jardine MJ, Bompoint S, Cannon CP, Neal B, Heerspink HJL, Charytan DM, Edwards R, Agarwal R, Bakris G, Bull S, Capuano G, de Zeeuw D, Greene T, Levin A, Pollock C, Sun T, Wheeler DC, Yavin Y, Zhang H, Zinman B, Rosenthal N, Brenner BM, Perkovic V. Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups. Circulation. 2019 08 27; 140(9):739-750.
-
Wali RK, Bianchi L, Kupfer S, De La Cruz M, Jovanovic B, Weber C, Goldberg MJ, Rodriguez LM, Bergan R, Rubin D, Tull MB, Richmond E, Parker B, Khan S, Roy HK. Prevention of colonic neoplasia with polyethylene glycol: A short term randomized placebo-controlled double-blinded trial. PLoS One. 2018; 13(4):e0193544.
-
Grant JE, Chamberlain SR, Redden SA, Odlaug BL, van Ameringen M, Dougherty DD, Keuthen NJ, Kim SW. Placebo response in trichotillomania. Int Clin Psychopharmacol. 2017 11; 32(6):350-355.
-
Grant JE, Chamberlain SR. The placebo effect and its clinical associations in gambling disorder. Ann Clin Psychiatry. 2017 Aug; 29(3):167-172.
-
Ray KK, Ginsberg HN, Davidson MH, Pordy R, Bessac L, Minini P, Eckel RH, Cannon CP. Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control. Circulation. 2016 Dec 13; 134(24):1931-1943.
-
Morton AM, Furtado JD, Lee J, Amerine W, Davidson MH, Sacks FM. The effect of omega-3 carboxylic acids on apolipoprotein CIII-containing lipoproteins in severe hypertriglyceridemia. J Clin Lipidol. 2016 Nov - Dec; 10(6):1442-1451.e4.
-
Stein E, Bays H, Koren M, Bakker-Arkema R, Bisgaier C. Efficacy and safety of gemcabene as add-on to stable statin therapy in hypercholesterolemic patients. J Clin Lipidol. 2016 Sep-Oct; 10(5):1212-22.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|